Pioneering breakthrough in treatment of ‘devastating’ neurological disorder
IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease).
IB1001 demonstrated...
Covid portal start-up exceeds 1 million tests and creates offshoot venture
As the UK continues learning how to live with the pandemic, some key questions remain. Chiefly, how will the NHS grapple with the huge...
Shaping the science of oncology
Dr Fiona McLaughlin is the new Chief Scientific Officer of Avacta’s Therapeutics Division. She talks to Karen Southern about her mission to develop first...
Biotech pioneer tackles the biology of ageing
Living to a ripe old age is one thing. Enjoying a healthy, ripe old age is the challenge. Biotech veteran Dr Eric Leire aims...